OPRM1 and major depressive disorder: As impairments in the domains of reward processing, motivation and social functioning are characteristically associated with MDD (Callaghan et al., 2018, Kupferberg et al., 2016), it follows that drugs that activate the MOR system may have antidepressant properties.